VLYPO:NASDAQValley National Bancorp - 5.5% Fixed to Floating Rate Series B Non-Cumulative Perpetual Preferred Stock Analysis
Data as of 2026-05-09 - not real-time
$24.95
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Valley National Bancorp delivered a solid first‑quarter earnings beat, with revenue accelerating strongly year‑over‑year and operating margins remaining robust. The technical picture is flat: the 20‑day and 50‑day moving averages sit almost side‑by‑side, the RSI hovers around the neutral midpoint, and the MACD has just nudged into bullish territory, while price trades tightly between a clear support and resistance band.
Valuation concerns arise from a price‑to‑earnings multiple that sits well above the sector average, suggesting the stock may be priced for perfection. The dividend yield is attractive but appears unsustainable given the company’s cash‑to‑debt balance and the lack of disclosed cash flow generation. Overall, the stock sits at a crossroads between strong earnings momentum and a potentially overstretched valuation.
Valuation concerns arise from a price‑to‑earnings multiple that sits well above the sector average, suggesting the stock may be priced for perfection. The dividend yield is attractive but appears unsustainable given the company’s cash‑to‑debt balance and the lack of disclosed cash flow generation. Overall, the stock sits at a crossroads between strong earnings momentum and a potentially overstretched valuation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Quarterly earnings beat and strong profit margins
- Flat technical outlook with price near support/resistance
- High dividend yield but sustainability doubts
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Continued revenue growth trajectory
- Valuation still above peers
- Potential pressure from regulatory and credit environment
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained earnings growth and high operating efficiency
- Opportunity to capture upside if valuation compresses
- Strategic niche banking segments (e.g., cannabis, venture banking) offering future tailwinds
Key Metrics & Analysis
Financial Health
Revenue Growth23.80%
Profit Margin33.79%
P/E Ratio22.5
ROE8.56%
ROA1.04%
P/B Ratio1.9
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI51.1
Support$24.75
Resistance$25.06
MA 20$24.95
MA 50$24.90
MA 200$25.08
MACDBullish
VolumeDecreasing
Fear & Greed Index90.73
Valuation
GradeOvervalued
TypeBlend
Dividend Yield7.98%
Risk Assessment
Beta0.10
Volatility5.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.